Vergent Bioscience is usefully described as involved in "lighting up" cancer to enable fast and effective location and complete removal of tumors during resection surgery. Designated VGT-309, Vergents lead compound is a tumor-targeted fluorescent imaging agent designed to enable surgeons to see difficult-to-find or previously undetected tumors in real-time during surgery - effectively ensuring all tumor tissue is removed. With initial focus on evaluating VGT-309 for cancer in the lung, the potential i to expand its application to a wide range of solid tumors
